Has Sanjai Rao received payments from drug or device companies?

Yes. Drug and device makers reported $445,230 in general payments to Sanjai Rao across 400 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sanjai Rao did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sanjai Rao come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sanjai Rao

Psychiatry · San Diego, CANPI 1700993557

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $342,273 of the $445,230 with a category attached, or 76.9%. 9 manufacturers reported payments, led by Johnson & Johnson at 56.7% of the total. Reporting peaked in 2022 at $106,769 and has fallen 84.2% since, to $16,823 in 2025. Among psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$445,230in general payments, 2019–2025

Across 400 payments — averaging $1113.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$252K
Alkermes, Inc.$81K
Neurocrine Biosciences, Inc.$78K
Janssen Scientific Affairs, LLC$12K
Otsuka Pharmaceutical Development & Commercialization, Inc.$8K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$5K
plus $10K from 3 others

What the payments were for

Consulting fees$54,97212%
Speaking & faculty fees$342,27377%
Travel & lodging$38,0089%
Food & beverage$9,9772%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson(2 entities)	232	$252,363
Alkermes, Inc.	73	$81,332
Neurocrine Biosciences, Inc.	64	$77,723
Janssen Scientific Affairs, LLC	3	$11,675
Otsuka Pharmaceutical Development & Commercialization, Inc.	15	$7,765
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$4,628
Sunovion Pharmaceuticals Inc.	7	$4,486
E.r. Squibb & Sons, L.L.C.	2	$2,709
Otsuka America Pharmaceutical, Inc.	2	$2,550

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ARISTADA$270,254
INVEGA SUSTENNA$231,706
INVEGA TRINZA$215,429
INGREZZA$77,129
LYBALVI$62,682
ARISTADA INITIO$58,183
SPRAVATO$18,876
CAPLYTA$4,628
LATUDA$4,463
COBENFY$2,709
INVEGA$2,169

How this compares

$445,230 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in San Diego

Jonathan MeyerSan Diego$2.3M
Murray SteinSan Diego$121K
Gustavo AlvaOrange$5.8M
John KooSan Francisco$3M
Jason KelloggIrvine$2.7M
Charles Tuan-Tu NguyenIrvine$2.1M
Manoj WaikarLos Gatos$1.9M
Gerald MaguireSan Juan Capistraco$1.8M
Salima BrillmanSunnyvale$1.4M
Bibi DasStanford$1.4M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →